FDA Recalls Eye Ointment Product Due to Sterility Assurance Failure
The FDA is recalling Major LubriFresh PM eye ointment due to lack of assurance of sterility. Approximately 282,564 units were distributed to accounts in Rhode Island and Colorado.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile ophthalmic product without reported illnesses or injuries. While the lack of sterility assurance on an eye ointment presents a potential risk of infection, no actual contamination or adverse events have been reported in the source, warranting a High rating for this precautionary recall.
Plain-English summary
The FDA is recalling Major LubriFresh PM Nighttime Ointment, a sterile eye lubricant manufactured by Amman Pharmaceutical Industries. The product contains mineral oil and white petrolatum and is available in 0.125 ounce (3.5 gram) tubes with NDC 0904-6488-38.
The recall is due to lack of assurance of sterility. Approximately 282,564 units were distributed to accounts in Rhode Island and Colorado. The affected lots are 184001, 184002, and 184003 (expiration 11/24) and lots 184004, 184005, and 184006 (expiration 12/24).
Consumers who have purchased this product should discontinue use. Patients with questions should contact their healthcare provider or pharmacist.
The recalled product
- Product
- MAJOR LUBRIFRESH PM (MINERAL OIL AND WHITE PETROLATUM)
- Brand
- MAJOR LUBRIFRESH PM
- Manufacturer
- AMMAN PHARMACEUTICAL INDUSTRIES
- Category
- Drug — Ophthalmic
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot: 184001 EXP: 11/24
- 184002 EXP: 11/24
- 184003 EXP: 11/24
- Lot: 184004 EXP: 12/24
- Lot: 184005 EXP: 12/24
- Lot:184006 EXP:12/24
UPCs (1)
- 0309046488385
Distribution
Distributed in 2 states:
- CO
- RI
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27